Randomised studies have shown that switching to a TAFbased regimen is generally safer than continuing to take TDF-containing regimens, particularly for bone/kidney health. How these trial results might have impacted on daily prescriptions and the determinants of switching to TAF-based regimens have not been thoroughly investigated.
Determinans of switching to TAF.based cart or two-drug combinations with HIV.RNA <50cp/mL in a cohort of HIV.infected individuals seen for care in Italy.
G. NunnariMembro del Collaboration Group
;G. F. Pellicanò.Membro del Collaboration Group
2018-01-01
Abstract
Randomised studies have shown that switching to a TAFbased regimen is generally safer than continuing to take TDF-containing regimens, particularly for bone/kidney health. How these trial results might have impacted on daily prescriptions and the determinants of switching to TAF-based regimens have not been thoroughly investigated.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
